TriPoint Global Research Announces Investment Opinion on China Pharmaceuticals
HENDERSON, Nev.--(BUSINESS WIRE)--TriPoint Global Research publishes Update Research Report by Senior Analyst Stanley Ng, on China Pharmaceuticals, Inc. (OTCBB:CFMI)